Skip to main content
Premium Trial:

Request an Annual Quote

Inpharmatica and Ingenuity Pen Co-Marketing Alliance

NEW YORK, March 20 (GenomeWeb News) - Inpharmatica and Ingenuity Systems today said they have penned a co-marketing alliance for their drug-discovery tools.


Terms of the agreement call for Inpharmatica to co-market its Blu-Chip probe-to-protein assignment module with Ingenuity's Pathway Analysis.

 

The alliance will enable researchers to move through two steps of analysis: probe assignment and protein network analysis, the companies said.

 

Details were not disclosed.

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.